Skip to content

Clinical study of oral administration of Lianqi Pills to promote postoperative wound repair after TROPIS surgery for intersphincteric anal fistula

Clinical study of oral administration of Lianqi Pills to promote postoperative wound repair after TROPIS surgery for intersphincteric anal fistula

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001208
Enrollment
Unknown
Registered
2025-06-18
Start date
2025-06-25
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

anal fistula

Interventions

Control group:Routine dressing changes
Test group:Take Lianqi Pills orally

Sponsors

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Meet the western medical diagnostic criteria of inter-sphincteric anal fistula and the Chinese medical diagnostic criteria of anal fistula with syndrome of dampness-heat diffusing downward; (2) Age =18 years old and =65 years old gender is not limited; (3) intend to undergo transanal opening of intersphincteric space in our hospital without contraindications to surgery; (4) Knowing and agreeing to participate in this study willing to receive treatment according to the requirements regular follow-up and not practical any drugs that may affect postoperative wound healing during the treatment period and signing the informed consent form.

Exclusion criteria

Exclusion criteria: (1) Combined with hematopoietic and coagulation disorders; (2) Those with a combination of serious cardiovascular cerebrovascular and hepatic or renal diseases or uncontrolled metabolic diseases; (3) Those with the combination of tuberculosis tumor inflammatory bowel disease or other diseases that may affect postoperative wound healing; (4) Those who have a recent need to prepare for pregnancy or are in the period of pregnancy or breastfeeding; (5) Those who have uncontrolled mental illnesses and cannot cooperate with the whole process during the treatment; (6) Those who are allergic to the drugs used in this study; (7) Participating in other clinical studies at the same time.

Design outcomes

Primary

MeasureTime frame
The postoperative wound healing rate in the first month;

Secondary

MeasureTime frame
Macrophage polarization in wound tissue;Recurrence rate;Wound healing time;Postoperative wound inflammatory factors;Detection of 16sr RNA of wound microbiota;Wound evaluation tool score for improved wound images;

Countries

China

Contacts

Public ContactZhenyi Wang

Yueyang Hospital of Integrated Traditional Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine

drxinhuo@163.com18917073775

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026